SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
HIV-1 AND SARS-CoV-2: DURABILITY OF HOST IMMUNE RESPONSES FROM VACCINATION OR INFECTION
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
7 of
7
|
SESSION OVERVIEW
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Guido Silvestri
Emory University, Atlanta, GA, USA
HUMORAL RESPONSES AGAINST THE SARS-COV-2 SPIKE
Andrés Finzi
Université de Montréal, Montreal, Canada
T CELL IMMUNITY IN SARS-COV-2 NATURAL INFECTION AND FOLLOWING VACCINATION
Julie McElrath
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
LONGITUDINAL ANTIBODY RESPONSES TO SARS-COV-2 AND EMERGING VARIANTS
Katie J Doores
King's College London, London, United Kingdom
PROGRAMMING DURABLE IMMUNITY
Robert Seder
Vaccine Research Center, Bethesda, MD, USA
PATHOLOGICAL B CELL ACTIVATION DURING SARS-COV-2 INFECTION
Ignacio Sanz
Emory University, Atlanta, GA, USA
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
7 of
7
|